Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Feb;4(1):23-30.
doi: 10.1007/s11894-002-0034-y.

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin

Markus Cornberg  1 , Heiner Wedemeyer, Michael P Manns
Affiliations
Review

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin

Markus Cornberg et al. Curr Gastroenterol Rep. 2002 Feb.

Abstract

Treatment with interferon alfa combined with ribavirin is successful in approximately 40% to 45% of patients with chronic hepatitis C viral infection (HCV). However, response rates are disappointing in patients who are difficult to treat, such as those infected with HCV genotype 1, high viral load, or advanced liver fibrosis. In addition, low tolerability and significant side effects of therapy frequently lead to dose reduction and treatment discontinuation, decreasing response rates further. Thus, investigation of new treatment options and innovations for chronic HCV infection are vital. This review describes recent advances in the treatment of HCV infection with PEGylated interferon (interferon modified with polyethylene glycol [PEG] ) combined with ribavirin.

PubMed Disclaimer

References

    1. Gastroenterology. 1999 Feb;116(2):378-86 - PubMed
    1. N Engl J Med. 1998 Nov 19;339(21):1485-92 - PubMed
    1. Gut. 2001 Sep;49(3):423-30 - PubMed
    1. Lancet. 1998 Oct 31;352(9138):1426-32 - PubMed
    1. Gastroenterology. 1999 Nov;117(5):1164-72 - PubMed

MeSH terms

LinkOut - more resources